Western blot analysis showed that FADD was overexpressed in the tumours after VNP-FADD treatment; furthermore, the protein levels of FADD and cleaved caspase-3 were upregulated after the combined ADT-OH treatment (Fig. 5h). The gene discussed is CASP3; the disease is neoplasm.